Korenberg Matthew E
CIK 0001649903
President & Chief OperatingDirector
Filings
22
Latest Feb 9, 2026
Issuers covered
3
Showing
22 of 22
Page 1
Track record
13 of 13 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 13 | 62% | +0.7% | +4.0% | +6.1% | -7.3% |
| 90 days | 13 | 0% | -15.1% | -14.2% | -7.7% | -29.7% |
| 180 days | 13 | 0% | -20.6% | -15.8% | -5.1% | -46.9% |
| 365 days | 13 | 0% | -50.9% | -52.9% | -23.2% | -71.2% |
Issuers
Companies where Korenberg Matthew E has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 17 | Sep 24, 2024 |
| PIRS | Pieris Pharmaceuticals, Inc. | 3 | Feb 9, 2026 |
| LFCR | Lifecore Biomedical, Inc. \de\ | 2 | Jul 17, 2025 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|